Pure Global AI
Disease / condition

Schizophrenia clinical trials

Free access to 2,119 studies10+ countriesUpdated daily248 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
2,119
Total trials
10+
Countries
10+
Sponsors
248
Recruiting
By phase
N/A900
Phase 3328
Phase 4232
Phase 2213
Phase 1194
By status
Completed1,291
Recruiting248
Unknown247
Terminated119
Not yet recruit...111
Top countries
United States of America446
China229
Iran168
Japan129
United Kingdom80
Top sponsors
Johnson & Johnson ...52
Otsuka Pharmaceuti...47
AstraZeneca46
Shanghai Mental He...45
H. Lundbeck A/S32
Recent trials
Latest clinical trials for Schizophrenia
Correlates of Fatigue in People With Schizophrenia
GCS CIPS
NCT06397950Not yet recr...
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
The University of Texas Health... · United States of America
NCT06345963Not yet recr...
The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia
Massachusetts General Hospital · United States of America
NCT06386588Not yet recr...
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity
LMU Klinikum
NCT06315972Not yet recr...
Phase
Phase 2
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia
Teva Branded Pharmaceutical Pr... · United States of America
NCT06315283Recruiting
Phase
Phase 1
The Phase I Study of HS-10509 in Chinese Adult Subjects
Jiangsu Hansoh Pharmaceutical ... · China
NCT06301074Not yet recr...
Phase
Phase 1
Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia
Rovi Pharmaceuticals Laborator... · Jordan
NCT06276361Recruiting
Phase
Phase 1
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
Teva Branded Pharmaceutical Pr... · China
NCT06253546Recruiting
Phase
Phase 1
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
All India Institute of Medical...
NCT06236451Not yet recr...
Phase
Phase 4
Energetics and Glutamate in Schizophrenia
King's College London · United Kingdom
NCT06236048Recruiting
The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study
Sir Run Run Shaw Hospital · China
NCT06231732Recruiting
A Study of ANAVEX3-71 in Adults With Schizophrenia
Anavex Life Sciences Corp. · United States of America
NCT06245213Recruiting
Phase
Phase 2
TMS for Inhibition Enhancement in Schizophrenia
University of Maryland, Baltim...
NCT06155682Not yet recr...
Intermittent Theta Burst Stimulation of the Precuneus
GCS Ramsay Santé pour l'Enseig... · France
NCT06142422Not yet recr...
A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia
Click Therapeutics, Inc. · United States of America
NCT06136936Recruiting
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
Vigonvita Life Sciences · China
NCT06105151Recruiting
Phase
Phase 1
Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study
Central South University · China
NCT06123897Not yet recr...
CAE for Poorly Adherent Individuals With Schizophrenia
Martha Sajatovic · United States of America
NCT06061952Not yet recr...
Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
Otsuka Pharmaceutical Co., Ltd... · Japan
NCT06036108Recruiting
Phase
Phase 1
Exercise Intervention for People With Schizophrenia (CREW)
Università degli Studi di Ferr... · Italy
NCT06044038Recruiting
View all 2,119 trials →
About this profile

Access comprehensive clinical trial information for Schizophrenia through Pure Global AI's free database. This collection includes 2,119 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 248 trials are actively recruiting participants.

Research for Schizophrenia is being conducted in United States of America, China, Iran and 7+ other countries. Leading sponsors include Johnson & Johnson Pharmaceutical Research & Development, L.L.C. and Otsuka Pharmaceutical Development & Commercialization, Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 2,119 clinical trials studying Schizophrenia, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Otsuka Pharmaceutical Development & Commercialization, Inc., AstraZeneca, among others.